Topadur Pharma AG

Topadur Pharma AG is located in Schlieren, Switzerland on Grabenstrasse 11A. Topadur Pharma AG is rated 5 out of 5 in the category company in Switzerland. With innovation, creativity and the latest technology, CEO Reto Naef and his team of experts at TOPADUR PHARMA AG ("TOPADUR"​) won not only the Swiss Technology Award in 2016 but also the prestigious "Swiss Innovative Challenge"​ in November 2017. The very promissing young and dynamic biotech start-up from Schlieren ZH is able now to move into global markets and continually create new jobs. TOPADUR develops two promising drugs in the area of wound healing for the treatment of non-healing wounds and to avoid excessive scar formation in burn wounds. The active substance and medical compound "TOP-N53"​ could offer all diabetics with chronic foot wounds essential support in avoiding amputations and extend their lives. The drugs produced by TOPADUR cover major medical requirements that burden the global healthcare budget to the tune of more than USD 24 billion every year. Reto Naef founded TOPADUR in 2015 and today engages 15 employees. More details about TOPADUR are available on the website of the company on www.topadur.com